Crossmark

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy

Crossref DOI link: https://doi.org/10.1080/2162402X.2019.1608106

Published Online: 2019-05

Published Print: 2019-08-03

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Findlay, Emily Gwyer

Currie, Andrew J.

Zhang, Ailiang

Ovciarikova, Jana

Young, Lisa

Stevens, Holly

McHugh, Brian J.

Canel, Marta

Gray, Mohini

Milling, Simon W.F.

Campbell, John D.M.

Savill, John

Serrels, Alan

Davidson, Donald J. https://orcid.org/0000-0002-8782-199X
Funding

Funding for this research was provided by:

Medical Research Council (grant number G1002046)

Royal Society ([grant number DH150175]; MRC [grant number G1002046], [grant number G0802069])
License Information

License valid from 2019-05-01
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=koni20

Publication History

Received: 2019-03-08

Accepted: 2019-03-13

Published: 2019-05-01